Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street rises with investors rotating into healthcare and value stocks
- Brent slips as Iran president discusses mediation with Pakistan army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 230.39 -2.9 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $233.29 | 52 Week High | $109.10 | |||
| Open | $237.73 | 52 Week Low | $31.38 | |||
| Day High | $238.96 | P/E | N/A | |||
| Day Low | $229.54 | EPS | $-1.45 | |||
| Volume | 953,333 | |||||
